Resources

Explore Panalgo thought leadership, white papers and booklets, case studies, webinars, videos, and more.

Travel Burden Associated with Rare Cancers: The Example of Merkel Cell Carcinoma

Publication
February 19, 2019

Authors: R Jain, J Menzin, K Lachance, P McBee, H Phatak Published: Cancer Medicine, 2019. Click here for the article.

News & Events
January 15, 2019

BHE is excited to announce the opening of our new corporate headquarters located in the heart of Boston’s Financial District at 265 Franklin St. Due...

Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database

Publication
November 29, 2018

Authors: J Shaw, L Johns, C Harvey, C Richards and C Kim Published: Blood, 2018.

Pregnancy rates and outcomes in women with and without MS in the United States

Publication
September 28, 2018

Authors: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips Published: Neurology, 2018. Click here for the article.

Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives

Publication
August 24, 2018

Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.

Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder

Publication
May 1, 2018

Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.

Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.

Publication
March 29, 2018

Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,...

Panalgo to Present at ICPE 2020

September 2, 2020

The 2020 virtual International Conference for Pharmacoepidemiology (ICPE) takes place September 16-17. Panalgo will be sharing the following research during the virtual event, please join

5 Steps To Prepare For A Third-Party Drug Price Evaluation

September 1, 2020

In this Life Science Leader article, Matt Sussman discusses important steps to take when preparing for a third party drug price evaluation. Sussman notes that

Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders

August 20, 2020

Authors: Matthew Sussman, Jeffrey C Yu, Joseph Menzin Published: Applied Health Economics Health Policy Click here to view the article.

BHE is Now Panalgo: Why We Changed Our Name and Brand

July 27, 2020

In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic

BHE Announces Rebrand to Panalgo, Continues Its Mission of Leadership in Analytics Software for Healthcare [Press Release]

July 27, 2020

BOSTON, Mass. – July 27, 2020 – BHE, a leading healthcare analytics company, is now Panalgo. The new name reflects the company’s commitment to expanding the accessibility

The Pressure To Publish Rapidly: The Risks Vs. Rewards Of Fast-Tracked COVID-19 Studies

July 15, 2020

In this article with Health IT Outcomes, Joseph Menzin discusses fast-tracked COVID-19 studies, noting that with the fear surrounding the pandemic and the pressure to both

IHD Analytics

Put reliable, rapid analytics in the hands of more people across your organization

Learn more about Panalgo

Get the story behind our work and our team.